Navigation Links
Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
Date:12/1/2008

Presentation to Highlight Results of Ocular Neuroprotection Candidate

FREMONT, Calif., Dec. 1 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that its Chief Operating Officer, Dr. Rami Skaliter is scheduled to present results on the Company's ocular neuroprotection candidate at the 20th Annual Piper Jaffray Health Care Conference to be held December 2-3, 2008 at the New York Palace in New York City.

                       Event: 20th Annual Piper Jaffray Health Care Conference
                       Date:  Tuesday, December 2, 2008
                       Time:  11:30 am ET

As previously announced, the ocular neuroprotection candidate is the Company's first RNAi drug candidate having a novel, proprietary structure covered by Quark's intellectual property. Data has validated its neuroprotective effects on dying retinal ganglion cells, a cause of blindness and glaucoma.

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical company engaged in discovering and developing novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. Quark's RNAi technology includes novel siRNA structures and chemistry providing Quark with freedom to operate in the siRNA intellectual property arena, as well as the ability for non-invasive delivery of siRNA to target tissues including the eye, ear, kidney, lung, spinal cord and brain.

PF-4523655 (RTP801i-14), currently in Phase II clinical trials, is a synthetic, chemically modified, siRNA molecule to inhibit the expression of the gene RTP801 discovered by Quark through the gene discovery platform BiFAR. PF-4523655 is licensed to Pf
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... RankingBySEO, a prominent internet marketing company, ... organizations against whom negative reviews are there. The company ... , About the service, a senior management executive ... service now, but we have been helping individuals and ... several years.” , On being asked about the service ...
(Date:7/31/2014)... 31, 2014 T.E.N., a technology ... honored finalists and winners Wednesday evening, July 30, ... Awards Gala at the Westin St. Francis in ... information security for the BlackLine Systems, was selected ... Award winner for the ISE® West Region. As ...
(Date:7/31/2014)... HealthDay Reporter , WEDNESDAY, July 30, ... isn,t warranted based on current evidence, a team of ... compete with regular cigarettes might cut tobacco-related deaths and ... on the use and safety of the nicotine-emitting devices. ... a potential for smokers to reduce their health risks ...
(Date:7/31/2014)... Delhi, India (PRWEB) July 31, 2014 ... Internet Marketing Company, has introduced a new service ... affordable.     , Ethane Web Technologies has designed the ... expectations of clients and Java Development service being ... given the company a confidence to promise outstanding ...
(Date:7/31/2014)... Bedros Keuilian’s Fit Body Boot Camp franchise has locations ... his annual Fitness Business Summits, some of the highest earners ... But in his latest blog post, he shares that one ... training business is to create free fitness info products ... a certain area that they really feel strongly about or ...
Breaking Medicine News(10 mins):Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 2Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 4Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 3
... ... Cloud Enhances Company’s Suite of International Hosting and Managed Services. , ... Mississauga, Ontario (PRWEB) ... managed services, today announced that it has launched the first international, multi-infrastructure ...
... , ... Magazine presents the 2nd annual “Top OTC/Healthcare Marketers of the Year” awards, hosted by ... ... April 7, 2010 -- OTC Perspectives, Inc. , the leading conference, training and ...
... ... world and sharing her story of hope and determination. , ... Bayfield, WI (PRWEB) April 7, 2010 -- Hopeful climbers have begun streaming in ... world,s highest peak. Last year,s successful climbers whose summit of Everest also completed ...
... ... for body sculpting. Surprisingly Zerona has also been clinically shown to reduce the resistance ... of Lipoprotein (LDL). , ... Houston, TX (PRWEB) April 6, 2010 -- A 22 participant pilot study revealed ...
... ... about your brand, advertising campaign, competitors or product innovations. , ... (PRWEB) April 6, 2010 -- Six Degrees ... easy, affordable way to gather insights needed to optimize marketing strategies, increase advertising effectiveness, ...
... returns to hospital for treatment, at higher rates than expected ... cell disease often visit hospitals repeatedly in search of treatment, ... found that one-third of sickle cell patients who visited the ... Young people, between the ages of 18 and 30, were ...
Cached Medicine News:Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 2Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 3Health News:Top OTC/Consumer Healthcare Marketers of 2010 Announced 2Health News:Top OTC/Consumer Healthcare Marketers of 2010 Announced 3Health News:Top OTC/Consumer Healthcare Marketers of 2010 Announced 4Health News:Woman with MS Summits Everest and Completes the Seven Summits 2Health News:Woman with MS Summits Everest and Completes the Seven Summits 3Health News:"Zerona" Lipo-Laser Penetrates Wellness Industry for Anti-aging, Weight Loss, Body Sculpting and Cardiac Health 2Health News:"Zerona" Lipo-Laser Penetrates Wellness Industry for Anti-aging, Weight Loss, Body Sculpting and Cardiac Health 3Health News:Sickle Cell Disease Patients Seek Acute Pain Care Repeatedly 2Health News:Sickle Cell Disease Patients Seek Acute Pain Care Repeatedly 3
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
(Date:7/31/2014)... juli 2014 De Pfizer Clinical Research Unit ... gezonde vrijwilligers van Japanse komaf voor medewerking aan klinisch ... PCRU is één van twee onderzoekseenheden van Pfizer ... te verbeteren door de ontdekking en ontwikkeling van nieuwe ... zoek naar mannen en vrouwen van Japanse komaf – ...
(Date:7/30/2014)... SUNNYVALE, Calif. , July 30, 2014 /PRNewswire/ ... that its group purchasing contract with Premier will ... through the Premier GPO will be able to ... including Amerinet, Baycare, HPA, MedAssets, Novation, and ROi, ... HealthTrust, or directly with Cepheid. "Cepheid ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
... Mass., May 9, 2011 CardioFocus, Inc., developer of ... of Atrial Fibrillation (AF), announced its technology enables a ... with approximately 86% of PVs remaining persistently isolated after ... patients achieve durable freedom from AF after a single ...
... 2011 Reportlinker.com announces that a new market research ... Brazil Biomaterial Market (2010 – 2015) ... The Brazil market for biomaterials is expected ... in 2008 with a CAGR of 19.5% from 2010 ...
Cached Medicine Technology:New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 2New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 3Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 2Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 3Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 4Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 5Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 6Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 7Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 8Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 9Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 10Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 11
... anti-PSA antibody gives positive staining of ... benign hyperplasia. In cases of prostatic ... 34% give definite but weak staining ... of cells; this pattern of staining ...
... Wampole Laboratories offers a comprehensive line of ... serum and urine in convenient one-step stick ... 2 testing options. Clearview Easy HCG is ... convenient stick format. Clearview HCG II ...
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
Medicine Products: